Samuel Lanyon
Good morning, everybody. My identify is Sam Lanyon, Chair of Lumos Diagnostics Holdings Restricted, and it’s my pleasure to welcome you all to our Annual Normal Assembly of Shareholders. I would like to begin by acknowledging and paying respect to the standard custodians of the land wherever these taking part at this assembly are positioned.
At this time’s assembly is being held in a digital format, permitting shareholders and their representatives to take part through the webinar discussion board. And as such, we could expertise a while lag, and this will likely trigger delay in your questions or feedback coming to our consideration.
I additional suggested that the corporate has complied with the related necessities for convened assembly and {that a} quorum is current. Time is round 9:32 a.m., and I formally declare the assembly open. I am joined by means of the webcast in the present day by my fellow administrators, Managing Director and CEO, Doug Ward; and our Non-Govt Administrators, Catherine Robson, Bronwyn Le Grice and Lawrence Mehren. Our audit accomplice, Alan Finnis, representing William Buck, our exterior audit accomplice can be in attendance and can make himself obtainable throughout the assembly to reply any questions on the FY ’25 audit on the acceptable time.
Additionally, our CFO, Barrie Lambert; and Firm Secretary, Tracy Weimar are additionally in attendance in the present day. The Discover of Assembly has been given in accordance with the corporate’s structure, and copies can be found for you on the corporate’s web site and the share registry’s on-line voting website. Except there are any objections, I intend to take the discover of this assembly, connected explanatory assertion and the addendum to the Discover of Assembly despatched to shareholders as learn.
